Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 817070501 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
American Century Investment Management, Inc.
13G
|
5.6% |
8/14/2026
Event 6/30/2026
|
|
| American Century ETF Trust | 5.2% | ||
| American Century Investment Management, Inc. | 5.6% | ||
| American Century Companies, Inc. | 5.6% | ||
| Stowers Institute for Medical Research | 5.6% | ||
| Vanguard Group Inc 13G/A Amendment 8 | 0% |
3/27/2026
Event 3/13/2026
|
|
| Vanguard Group Inc 13G/A Amendment 7 | 6.6% |
10/30/2025
Event 9/30/2025
|
|
| Royce & Associates LP 13G/A Amendment 2 | 4.9% |
10/22/2025
Event 9/30/2025
|
|
| Royce & Associates LP 13G | 5.7% |
1/28/2025
Event 12/31/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 6 | 615 | $109 k |
| 2026 Q2 | 226 | 4.96 M | $709 M |
| 2026 Q1 | 203 | 3.74 M | $556 M |
| 2025 Q4 | 180 | 3.65 M | $403 M |
| 2025 Q3 | 172 | 3.51 M | $378 M |
| 2025 Q2 | 163 | 3.19 M | $324 M |
| 2025 Q1 | 137 | 2.83 M | $252 M |
| 2024 Q4 | 122 | 2.81 M | $217 M |
| 2024 Q3 | 120 | 2.83 M | $176 M |
| 2024 Q2 | 104 | 2.79 M | $160 M |
| 2024 Q1 | 108 | 2.94 M | $167 M |
| 2023 Q4 | 102 | 3.10 M | $158 M |
| 2023 Q3 | 103 | 3.13 M | $168 M |
| 2023 Q2 | 111 | 4.11 M | $134 M |
| 2023 Q1 | 121 | 4.04 M | $211 M |
| 2022 Q4 | 130 | 4.27 M | $260 M |
| 2022 Q3 | 116 | 4.23 M | $213 M |
| 2022 Q2 | 113 | 4.61 M | $256 M |
| 2022 Q1 | 115 | 4.71 M | $242 M |
| 2021 Q4 | 118 | 4.82 M | $231 M |
| 2021 Q3 | 118 | 5.06 M | $244 M |
| 2021 Q2 | 120 | 5.26 M | $269 M |
| 2021 Q1 | 122 | 5.33 M | $251 M |
| 2020 Q4 | 114 | 5.97 M | $239 M |
| 2020 Q3 | 116 | 5.27 M | $188 M |
| 2020 Q2 | 109 | 4.88 M | $165 M |
| 2020 Q1 | 110 | 4.68 M | $186 M |
| 2019 Q4 | 96 | 4.76 M | $194 M |
| 2019 Q3 | 92 | 4.56 M | $142 M |
| 2019 Q2 | 83 | 4.59 M | $128 M |
| 2019 Q1 | 88 | 4.70 M | $116 M |
| 2018 Q4 | 92 | 4.71 M | $133 M |
| 2018 Q3 | 91 | 5.46 M | $184 M |
| 2018 Q2 | 90 | 5.41 M | $146 M |
| 2018 Q1 | 93 | 5.41 M | $150 M |
| 2017 Q4 | 91 | 5.42 M | $167 M |
| 2017 Q3 | 95 | 5.44 M | $188 M |
| 2017 Q2 | 98 | 5.44 M | $169 M |
| 2017 Q1 | 109 | 4.89 M | $177 M |
| 2016 Q4 | 122 | 4.84 M | $194 M |
| 2016 Q3 | 104 | 4.64 M | $131 M |
| 2016 Q2 | 112 | 4.66 M | $168 M |
| 2016 Q1 | 110 | 4.71 M | $163 M |
| 2015 Q4 | 97 | 4.75 M | $138 M |
| 2015 Q3 | 90 | 5.00 M | $132 M |
| 2015 Q2 | 88 | 4.87 M | $135 M |
| 2015 Q1 | 89 | 4.91 M | $146 M |
| 2014 Q4 | 89 | 5.82 M | $157 M |
| 2014 Q3 | 90 | 5.80 M | $166 M |
| 2014 Q2 | 95 | 5.92 M | $181 M |
| 2014 Q1 | 91 | 5.91 M | $186 M |